Skip to main content

Acetaminophen Versus IV Hydromorphone for Pain in the Elderly in the ED

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Acetaminophen Versus IV Hydromorphone for Pain in the Elderly in the ED

The Selective Personalized Radio-Immunotherapy for Locally Advanced NSCLC Trial.

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about The Selective Personalized Radio-Immunotherapy for Locally Advanced NSCLC Trial.

Abiraterone With Discontinuation of Gonadotropin-Releasing Hormone Analogues in Metastatic Prostate Cancer

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Abiraterone With Discontinuation of Gonadotropin-Releasing Hormone Analogues in Metastatic Prostate Cancer

A Dose Finding Study of CycloSam® Combined With External Beam Radiotherapy

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Dose Finding Study of CycloSam® Combined With External Beam Radiotherapy

A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)

Post-op Outcomes of Enhanced Energy Delivery Dissection for Mastectomy With Immediate Breast Reconstruction

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Post-op Outcomes of Enhanced Energy Delivery Dissection for Mastectomy With Immediate Breast Reconstruction

Phase I Study of Fractionated Stereotactic Radiation Therapy

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Phase I Study of Fractionated Stereotactic Radiation Therapy

Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer

Family Groups for Urban Youth With Disruptive Behavior

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Family Groups for Urban Youth With Disruptive Behavior

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 230
  • Page 231
  • Page 232
  • Page 233
  • Page 234
  • Page 235
  • Page 236
  • Page 237
  • Page 238
  • …
  • Next page Next
  • Last page Last
Subscribe to